Anavex Reports Fiscal Third Quarter 2017 Financial Results

Anavex Reports Fiscal Third Quarter 2017 Financial Results

NEW YORK – August 7, 2017 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental...